

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 8.52527539 |
| 2 | protein-chromophore linkage (GO:0018298) | 7.35784929 |
| 3 | relaxation of smooth muscle (GO:0044557) | 7.25439083 |
| 4 | multicellular organismal reproductive behavior (GO:0033057) | 6.96110422 |
| 5 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 6.78299508 |
| 6 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 6.71282524 |
| 7 | negative regulation of myotube differentiation (GO:0010832) | 6.21850752 |
| 8 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.55164931 |
| 9 | meiotic chromosome segregation (GO:0045132) | 5.08986390 |
| 10 | transmission of nerve impulse (GO:0019226) | 5.05106639 |
| 11 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.93349841 |
| 12 | positive regulation of extracellular matrix organization (GO:1903055) | 4.74445500 |
| 13 | long term synaptic depression (GO:0060292) | 4.72109375 |
| 14 | viral entry into host cell (GO:0046718) | 4.69858871 |
| 15 | multi-organism reproductive behavior (GO:0044705) | 4.63279260 |
| 16 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.60908597 |
| 17 | positive regulation of interleukin-2 production (GO:0032743) | 4.56515015 |
| 18 | reproductive behavior (GO:0019098) | 4.55368150 |
| 19 | synaptic transmission, dopaminergic (GO:0001963) | 4.19014922 |
| 20 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.07297282 |
| 21 | negative regulation of smooth muscle contraction (GO:0045986) | 4.00056243 |
| 22 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.95394432 |
| 23 | nitric oxide mediated signal transduction (GO:0007263) | 3.83499945 |
| 24 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.80990421 |
| 25 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 3.75275675 |
| 26 | dopamine transport (GO:0015872) | 3.74840644 |
| 27 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.73736961 |
| 28 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.72355547 |
| 29 | proline biosynthetic process (GO:0006561) | 3.70298745 |
| 30 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.68829093 |
| 31 | nephron tubule formation (GO:0072079) | 3.68030623 |
| 32 | cardiolipin metabolic process (GO:0032048) | 3.64220499 |
| 33 | NLS-bearing protein import into nucleus (GO:0006607) | 3.59752974 |
| 34 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.43210795 |
| 35 | entry into host cell (GO:0030260) | 3.41847425 |
| 36 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 3.41847425 |
| 37 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 3.41847425 |
| 38 | entry into host (GO:0044409) | 3.41847425 |
| 39 | entry into other organism involved in symbiotic interaction (GO:0051828) | 3.41847425 |
| 40 | movement in host environment (GO:0052126) | 3.41847425 |
| 41 | plasma membrane fusion (GO:0045026) | 3.40882729 |
| 42 | hydrogen peroxide catabolic process (GO:0042744) | 3.40645111 |
| 43 | cytoplasmic microtubule organization (GO:0031122) | 3.32231701 |
| 44 | response to host immune response (GO:0052572) | 3.31358027 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.31358027 |
| 46 | L-methionine salvage (GO:0071267) | 3.28122461 |
| 47 | L-methionine biosynthetic process (GO:0071265) | 3.28122461 |
| 48 | amino acid salvage (GO:0043102) | 3.28122461 |
| 49 | regulation of DNA-templated transcription, initiation (GO:2000142) | 3.25874646 |
| 50 | regulation of cGMP biosynthetic process (GO:0030826) | 3.20210222 |
| 51 | histone H4 deacetylation (GO:0070933) | 3.18590083 |
| 52 | methionine biosynthetic process (GO:0009086) | 3.16211662 |
| 53 | response to host (GO:0075136) | 3.14001181 |
| 54 | response to host defenses (GO:0052200) | 3.14001181 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14001181 |
| 56 | negative regulation of muscle contraction (GO:0045932) | 3.11905999 |
| 57 | tachykinin receptor signaling pathway (GO:0007217) | 3.07411623 |
| 58 | regulation of metalloenzyme activity (GO:0048552) | 3.05791658 |
| 59 | proline metabolic process (GO:0006560) | 3.03056775 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 3.02778962 |
| 61 | cGMP biosynthetic process (GO:0006182) | 3.02717087 |
| 62 | monoamine transport (GO:0015844) | 3.02249793 |
| 63 | relaxation of muscle (GO:0090075) | 3.00470095 |
| 64 | angiogenesis involved in wound healing (GO:0060055) | 2.98741011 |
| 65 | multicellular organism reproduction (GO:0032504) | 2.98318065 |
| 66 | thyroid gland development (GO:0030878) | 2.97911734 |
| 67 | regulation of platelet aggregation (GO:0090330) | 2.95550596 |
| 68 | thrombin receptor signaling pathway (GO:0070493) | 2.94471625 |
| 69 | pyrimidine-containing compound salvage (GO:0008655) | 2.94385087 |
| 70 | pyrimidine nucleoside salvage (GO:0043097) | 2.94385087 |
| 71 | regulation of megakaryocyte differentiation (GO:0045652) | 2.92904641 |
| 72 | regulation of interleukin-2 production (GO:0032663) | 2.92375335 |
| 73 | intestinal epithelial cell development (GO:0060576) | 2.92052712 |
| 74 | positive regulation of male gonad development (GO:2000020) | 2.91469853 |
| 75 | lung epithelial cell differentiation (GO:0060487) | 2.87531578 |
| 76 | positive regulation of cGMP metabolic process (GO:0030825) | 2.87438429 |
| 77 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.86951614 |
| 78 | maternal behavior (GO:0042711) | 2.84114492 |
| 79 | otic vesicle formation (GO:0030916) | 2.82249078 |
| 80 | macroautophagy (GO:0016236) | 2.81994310 |
| 81 | regulation of lipoprotein metabolic process (GO:0050746) | 2.80480878 |
| 82 | sensory perception of chemical stimulus (GO:0007606) | 2.80162057 |
| 83 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.78061245 |
| 84 | regulation of cGMP metabolic process (GO:0030823) | 2.74193324 |
| 85 | ectoderm development (GO:0007398) | 2.72690573 |
| 86 | glomerular visceral epithelial cell development (GO:0072015) | 2.72609870 |
| 87 | phenol-containing compound catabolic process (GO:0019336) | 2.72167506 |
| 88 | neurotransmitter catabolic process (GO:0042135) | 2.71580992 |
| 89 | lung cell differentiation (GO:0060479) | 2.69303313 |
| 90 | S-adenosylmethionine metabolic process (GO:0046500) | 2.68600994 |
| 91 | rhodopsin mediated signaling pathway (GO:0016056) | 2.68065180 |
| 92 | methionine metabolic process (GO:0006555) | 2.66586333 |
| 93 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.64559127 |
| 94 | UMP biosynthetic process (GO:0006222) | 2.64559127 |
| 95 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.64559127 |
| 96 | UMP metabolic process (GO:0046049) | 2.64559127 |
| 97 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.58817013 |
| 98 | positive regulation of myotube differentiation (GO:0010831) | 2.58173945 |
| 99 | regulation of female receptivity (GO:0045924) | 17.6355459 |
| 100 | female mating behavior (GO:0060180) | 15.4261220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.86206980 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.21726439 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.69403397 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.27614046 |
| 5 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.97705674 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68571218 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61897804 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39915925 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.19753951 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15467821 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13853643 |
| 12 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.03826597 |
| 13 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.85456718 |
| 14 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85456718 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.83227509 |
| 16 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.78346607 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72067783 |
| 18 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69278046 |
| 19 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.67254564 |
| 20 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66962893 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64159364 |
| 22 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.63395089 |
| 23 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63205706 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60864461 |
| 25 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.60696422 |
| 26 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.59778177 |
| 27 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.49801064 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47368917 |
| 29 | TCF4_23295773_ChIP-Seq_U87_Human | 1.43927131 |
| 30 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.43645857 |
| 31 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.41413267 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40204610 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38025213 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36342691 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23378210 |
| 36 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.23113580 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22849547 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17388163 |
| 39 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16862688 |
| 40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15966333 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14586193 |
| 42 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13847615 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.13735869 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13575204 |
| 45 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13560187 |
| 46 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 1.12200001 |
| 47 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11433876 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10878808 |
| 49 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09734818 |
| 50 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 1.09531875 |
| 51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08961580 |
| 52 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07724247 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07445322 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07433947 |
| 55 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07433275 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07305717 |
| 57 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07230863 |
| 58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06517810 |
| 59 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05730726 |
| 60 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05721163 |
| 61 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.05467590 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.05467590 |
| 63 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.04036506 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03692577 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03692577 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02893554 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02612301 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02419771 |
| 69 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02059472 |
| 70 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01792319 |
| 71 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01308929 |
| 72 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.00840025 |
| 73 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00495956 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00486611 |
| 75 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99857317 |
| 76 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99432309 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99403556 |
| 78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99281682 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98939832 |
| 80 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98566299 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97995329 |
| 82 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96826961 |
| 83 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.96071197 |
| 84 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95783819 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95444528 |
| 86 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94540820 |
| 87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94261987 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94052303 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 0.92617018 |
| 90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92247331 |
| 91 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.92141834 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91565677 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90023615 |
| 94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88274974 |
| 95 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.87055130 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86971276 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86664054 |
| 98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86664054 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85864115 |
| 100 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85851871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 7.86611106 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 7.04299124 |
| 3 | MP0002132_abnormal_respiratory_system | 5.88833258 |
| 4 | MP0000372_irregular_coat_pigmentation | 4.37332005 |
| 5 | MP0002163_abnormal_gland_morphology | 3.89152956 |
| 6 | MP0005379_endocrine/exocrine_gland_phen | 3.53825213 |
| 7 | MP0003879_abnormal_hair_cell | 3.28404878 |
| 8 | MP0005464_abnormal_platelet_physiology | 3.27679282 |
| 9 | MP0008004_abnormal_stomach_pH | 2.76875354 |
| 10 | MP0006276_abnormal_autonomic_nervous | 2.56351230 |
| 11 | MP0005187_abnormal_penis_morphology | 2.49356028 |
| 12 | MP0004381_abnormal_hair_follicle | 2.44005263 |
| 13 | MP0004885_abnormal_endolymph | 2.26887817 |
| 14 | MP0004130_abnormal_muscle_cell | 2.18751132 |
| 15 | MP0002653_abnormal_ependyma_morphology | 2.13479895 |
| 16 | MP0002909_abnormal_adrenal_gland | 1.95847801 |
| 17 | MP0002102_abnormal_ear_morphology | 1.92953919 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 1.83325266 |
| 19 | MP0008775_abnormal_heart_ventricle | 1.82325265 |
| 20 | MP0002736_abnormal_nociception_after | 1.78032969 |
| 21 | MP0003638_abnormal_response/metabolism_ | 1.73596386 |
| 22 | MP0001968_abnormal_touch/_nociception | 1.68455633 |
| 23 | MP0001851_eye_inflammation | 1.66799907 |
| 24 | MP0000230_abnormal_systemic_arterial | 1.65700258 |
| 25 | MP0005410_abnormal_fertilization | 1.63611805 |
| 26 | MP0010030_abnormal_orbit_morphology | 1.59554756 |
| 27 | MP0005360_urolithiasis | 1.55194807 |
| 28 | MP0008872_abnormal_physiological_respon | 1.46211768 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.44579461 |
| 30 | MP0000681_abnormal_thyroid_gland | 1.44134039 |
| 31 | MP0003866_abnormal_defecation | 1.38126984 |
| 32 | MP0003724_increased_susceptibility_to | 1.35733968 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.31403261 |
| 34 | MP0000383_abnormal_hair_follicle | 1.25173076 |
| 35 | MP0002090_abnormal_vision | 1.22528798 |
| 36 | MP0001664_abnormal_digestion | 1.13926659 |
| 37 | MP0001348_abnormal_lacrimal_gland | 1.11764066 |
| 38 | MP0003045_fibrosis | 1.10813339 |
| 39 | MP0003436_decreased_susceptibility_to | 1.10336877 |
| 40 | MP0003938_abnormal_ear_development | 1.09459832 |
| 41 | MP0009697_abnormal_copulation | 1.03198878 |
| 42 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02370768 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 0.97197534 |
| 44 | MP0005646_abnormal_pituitary_gland | 0.96788995 |
| 45 | MP0000647_abnormal_sebaceous_gland | 0.90217827 |
| 46 | MP0001501_abnormal_sleep_pattern | 0.88282481 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 0.88084638 |
| 48 | MP0005390_skeleton_phenotype | 0.87513291 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 0.87488641 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 0.86730827 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 0.85895292 |
| 52 | MP0001545_abnormal_hematopoietic_system | 0.85895292 |
| 53 | MP0002998_abnormal_bone_remodeling | 0.85210367 |
| 54 | MP0003119_abnormal_digestive_system | 0.84400456 |
| 55 | MP0000049_abnormal_middle_ear | 0.83585410 |
| 56 | MP0000613_abnormal_salivary_gland | 0.83579125 |
| 57 | MP0002249_abnormal_larynx_morphology | 0.81307307 |
| 58 | MP0004085_abnormal_heartbeat | 0.81282210 |
| 59 | MP0005670_abnormal_white_adipose | 0.79154072 |
| 60 | MP0003252_abnormal_bile_duct | 0.78490584 |
| 61 | MP0002168_other_aberrant_phenotype | 0.75865693 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 0.75201981 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.74439638 |
| 64 | MP0005535_abnormal_body_temperature | 0.73998943 |
| 65 | MP0001485_abnormal_pinna_reflex | 0.72783299 |
| 66 | MP0009278_abnormal_bone_marrow | 0.72567251 |
| 67 | MP0001756_abnormal_urination | 0.68141147 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 0.67072409 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 0.66281082 |
| 70 | MP0002282_abnormal_trachea_morphology | 0.66166510 |
| 71 | MP0010329_abnormal_lipoprotein_level | 0.63240066 |
| 72 | MP0005395_other_phenotype | 0.60955302 |
| 73 | MP0003718_maternal_effect | 0.59922572 |
| 74 | MP0001963_abnormal_hearing_physiology | 0.57274459 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.54408181 |
| 76 | MP0003646_muscle_fatigue | 0.53441725 |
| 77 | MP0010678_abnormal_skin_adnexa | 0.52193623 |
| 78 | MP0005385_cardiovascular_system_phenoty | 0.51724142 |
| 79 | MP0001544_abnormal_cardiovascular_syste | 0.51724142 |
| 80 | MP0002572_abnormal_emotion/affect_behav | 0.50877341 |
| 81 | MP0000685_abnormal_immune_system | 0.50255821 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 0.49797595 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 0.49109734 |
| 84 | MP0003878_abnormal_ear_physiology | 0.49109734 |
| 85 | MP0002972_abnormal_cardiac_muscle | 0.49102887 |
| 86 | MP0003137_abnormal_impulse_conducting | 0.48727963 |
| 87 | MP0002148_abnormal_hypersensitivity_rea | 0.48533640 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.47970417 |
| 89 | MP0008874_decreased_physiological_sensi | 0.47822783 |
| 90 | MP0001486_abnormal_startle_reflex | 0.45695680 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 0.45434128 |
| 92 | MP0009046_muscle_twitch | 0.44915123 |
| 93 | MP0003122_maternal_imprinting | 0.44508827 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.44389917 |
| 95 | MP0005620_abnormal_muscle_contractility | 0.44339235 |
| 96 | MP0010155_abnormal_intestine_physiology | 0.43124416 |
| 97 | MP0009763_increased_sensitivity_to | 0.42770598 |
| 98 | MP0000343_altered_response_to | 0.41736411 |
| 99 | MP0002733_abnormal_thermal_nociception | 0.41526226 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.41045074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Concave nail (HP:0001598) | 6.19794615 |
| 2 | Premature skin wrinkling (HP:0100678) | 5.66885446 |
| 3 | Short chin (HP:0000331) | 5.03572390 |
| 4 | Severe visual impairment (HP:0001141) | 5.01850272 |
| 5 | Conical tooth (HP:0000698) | 4.90840610 |
| 6 | 11 pairs of ribs (HP:0000878) | 4.68027578 |
| 7 | Prolonged bleeding time (HP:0003010) | 4.62309806 |
| 8 | Increased connective tissue (HP:0009025) | 4.47530197 |
| 9 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.46500144 |
| 10 | Menorrhagia (HP:0000132) | 4.45868966 |
| 11 | Rimmed vacuoles (HP:0003805) | 4.29897492 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.17165606 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.95787222 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 3.94314177 |
| 15 | Keratoconjunctivitis (HP:0001096) | 3.86667580 |
| 16 | Shoulder girdle muscle weakness (HP:0003547) | 3.86502876 |
| 17 | Increased mean platelet volume (HP:0011877) | 3.83157052 |
| 18 | Absent eyebrow (HP:0002223) | 3.71778771 |
| 19 | Pelvic girdle muscle weakness (HP:0003749) | 3.71622178 |
| 20 | Anhidrosis (HP:0000970) | 3.71593028 |
| 21 | Mesangial abnormality (HP:0001966) | 3.67534308 |
| 22 | Abnormal platelet volume (HP:0011876) | 3.58277133 |
| 23 | Hemiparesis (HP:0001269) | 3.48903940 |
| 24 | Hypoproteinemia (HP:0003075) | 3.45716964 |
| 25 | Petechiae (HP:0000967) | 3.37186432 |
| 26 | Epistaxis (HP:0000421) | 3.25917110 |
| 27 | Neonatal respiratory distress (HP:0002643) | 3.22329302 |
| 28 | Attenuation of retinal blood vessels (HP:0007843) | 3.18740990 |
| 29 | Hyperthyroidism (HP:0000836) | 3.16344897 |
| 30 | Prominent supraorbital ridges (HP:0000336) | 3.14964165 |
| 31 | Tubular atrophy (HP:0000092) | 3.11246572 |
| 32 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.10800862 |
| 33 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.10800862 |
| 34 | Purpura (HP:0000979) | 3.01896247 |
| 35 | Cerebellar dysplasia (HP:0007033) | 3.00188581 |
| 36 | Abnormality of the dental pulp (HP:0006479) | 2.98941709 |
| 37 | Hypoplasia of the fovea (HP:0007750) | 2.93764713 |
| 38 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.93764713 |
| 39 | Tinnitus (HP:0000360) | 2.91500231 |
| 40 | Pigmentary retinal degeneration (HP:0001146) | 2.85166949 |
| 41 | Relative macrocephaly (HP:0004482) | 2.74399601 |
| 42 | Abnormal pupillary function (HP:0007686) | 2.71682413 |
| 43 | Gingival bleeding (HP:0000225) | 2.70816005 |
| 44 | Brittle hair (HP:0002299) | 2.69965962 |
| 45 | Type II lissencephaly (HP:0007260) | 2.68028811 |
| 46 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.66045406 |
| 47 | Abnormality of the dental root (HP:0006486) | 2.64899558 |
| 48 | Taurodontia (HP:0000679) | 2.64899558 |
| 49 | Abnormality of permanent molar morphology (HP:0011071) | 2.64899558 |
| 50 | Hypoplastic nipples (HP:0002557) | 2.64230516 |
| 51 | Papillary thyroid carcinoma (HP:0002895) | 2.61074956 |
| 52 | Congenital hip dislocation (HP:0001374) | 2.56759698 |
| 53 | Type I diabetes mellitus (HP:0100651) | 2.55102064 |
| 54 | Hypoplastic iliac wings (HP:0002866) | 2.51071030 |
| 55 | Hypotrichosis (HP:0001006) | 2.49819622 |
| 56 | Abnormality of the fovea (HP:0000493) | 2.49776425 |
| 57 | Abnormality of molar (HP:0011077) | 2.48103762 |
| 58 | Abnormality of molar morphology (HP:0011070) | 2.48103762 |
| 59 | Autoimmune hemolytic anemia (HP:0001890) | 2.45761467 |
| 60 | Spinal rigidity (HP:0003306) | 2.45482381 |
| 61 | Soft skin (HP:0000977) | 2.45193149 |
| 62 | Decreased central vision (HP:0007663) | 2.42538995 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.40996504 |
| 64 | Abnormality of B cell number (HP:0010975) | 2.40547555 |
| 65 | Sex reversal (HP:0012245) | 2.40292288 |
| 66 | Abnormal sex determination (HP:0012244) | 2.40292288 |
| 67 | True hermaphroditism (HP:0010459) | 2.38657373 |
| 68 | Gaze-evoked nystagmus (HP:0000640) | 2.27423404 |
| 69 | Neonatal short-limb short stature (HP:0008921) | 2.27042411 |
| 70 | Oligodontia (HP:0000677) | 2.25120365 |
| 71 | Gastrointestinal dysmotility (HP:0002579) | 2.24430504 |
| 72 | Abnormality of the 4th metacarpal (HP:0010012) | 2.21911713 |
| 73 | Metaphyseal cupping (HP:0003021) | 2.17168739 |
| 74 | Central scotoma (HP:0000603) | 2.16642004 |
| 75 | Dysphonia (HP:0001618) | 2.14564078 |
| 76 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.13297627 |
| 77 | Thyroid-stimulating hormone excess (HP:0002925) | 2.09273479 |
| 78 | Abnormality of macular pigmentation (HP:0008002) | 2.07042674 |
| 79 | Optic nerve hypoplasia (HP:0000609) | 2.06352139 |
| 80 | Erythroderma (HP:0001019) | 2.05597314 |
| 81 | Abnormal tarsal ossification (HP:0008369) | 2.03545676 |
| 82 | Keratitis (HP:0000491) | 2.02335558 |
| 83 | Abnormal platelet function (HP:0011869) | 2.01671848 |
| 84 | Impaired platelet aggregation (HP:0003540) | 2.01671848 |
| 85 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.90212870 |
| 86 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88976339 |
| 87 | Hyperventilation (HP:0002883) | 1.87518606 |
| 88 | Absent hair (HP:0002298) | 1.87258723 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 1.87018790 |
| 90 | Lip pit (HP:0100267) | 1.85380446 |
| 91 | Sparse eyelashes (HP:0000653) | 1.85026397 |
| 92 | Pustule (HP:0200039) | 1.83982220 |
| 93 | Missing ribs (HP:0000921) | 1.82632209 |
| 94 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.82540881 |
| 95 | Scapular winging (HP:0003691) | 1.81994482 |
| 96 | Focal seizures (HP:0007359) | 1.81590430 |
| 97 | Severe Myopia (HP:0011003) | 1.80114733 |
| 98 | Hyperlipoproteinemia (HP:0010980) | 1.79834406 |
| 99 | Respiratory difficulties (HP:0002880) | 1.78260430 |
| 100 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.76049100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.22515298 |
| 2 | MST4 | 4.42972961 |
| 3 | CDK12 | 3.88082131 |
| 4 | ADRBK2 | 3.60863958 |
| 5 | MAP3K10 | 3.06089967 |
| 6 | KIT | 3.03073300 |
| 7 | IRAK3 | 2.97188707 |
| 8 | PINK1 | 2.49117678 |
| 9 | DAPK2 | 2.36214487 |
| 10 | BUB1 | 2.14843634 |
| 11 | STK38 | 1.91816124 |
| 12 | JAK3 | 1.90769945 |
| 13 | MAP2K7 | 1.78412383 |
| 14 | ERBB2 | 1.75899365 |
| 15 | TEC | 1.61866315 |
| 16 | MAPKAPK3 | 1.56126449 |
| 17 | SYK | 1.55253304 |
| 18 | TXK | 1.54380128 |
| 19 | BMX | 1.49327962 |
| 20 | ADRBK1 | 1.34672481 |
| 21 | TAF1 | 1.34094771 |
| 22 | PTK2B | 1.33757413 |
| 23 | PBK | 1.32217968 |
| 24 | MYLK | 1.30742466 |
| 25 | NUAK1 | 1.30695156 |
| 26 | MAP4K1 | 1.26649499 |
| 27 | FGR | 1.16711563 |
| 28 | PAK3 | 1.15966981 |
| 29 | MAP3K7 | 1.15804815 |
| 30 | ACVR1B | 1.13701599 |
| 31 | DAPK1 | 1.13220600 |
| 32 | PLK2 | 1.10945106 |
| 33 | EPHA2 | 1.03250993 |
| 34 | CAMKK2 | 0.97911736 |
| 35 | PRKCQ | 0.97610236 |
| 36 | CDK7 | 0.97037884 |
| 37 | TNK2 | 0.93691644 |
| 38 | GRK1 | 0.93523048 |
| 39 | PKN1 | 0.92195508 |
| 40 | CSF1R | 0.91870493 |
| 41 | PIK3CG | 0.91190792 |
| 42 | DAPK3 | 0.87324397 |
| 43 | PRKACG | 0.81284312 |
| 44 | AKT2 | 0.80837895 |
| 45 | LATS2 | 0.78793980 |
| 46 | ARAF | 0.77925802 |
| 47 | PRKCE | 0.77880214 |
| 48 | CAMKK1 | 0.77266946 |
| 49 | STK3 | 0.75383486 |
| 50 | ROCK1 | 0.74234502 |
| 51 | BTK | 0.71863744 |
| 52 | CAMK2A | 0.70323889 |
| 53 | TAOK3 | 0.69006362 |
| 54 | GRK5 | 0.67646119 |
| 55 | HCK | 0.67029482 |
| 56 | TBK1 | 0.61961784 |
| 57 | EGFR | 0.61560076 |
| 58 | IKBKB | 0.61461275 |
| 59 | MKNK2 | 0.61349444 |
| 60 | STK10 | 0.60991639 |
| 61 | PRKD1 | 0.59179111 |
| 62 | WNK3 | 0.58208588 |
| 63 | LCK | 0.58122519 |
| 64 | PRKCA | 0.57110299 |
| 65 | MATK | 0.55790809 |
| 66 | PIM2 | 0.55758421 |
| 67 | LATS1 | 0.55163136 |
| 68 | DYRK2 | 0.52670106 |
| 69 | PRKCD | 0.52444849 |
| 70 | LMTK2 | 0.52334816 |
| 71 | PRKAA2 | 0.52198730 |
| 72 | CAMK2D | 0.52172888 |
| 73 | KDR | 0.50931256 |
| 74 | VRK2 | 0.50680484 |
| 75 | PRKCI | 0.50298406 |
| 76 | HIPK2 | 0.50144270 |
| 77 | PRKCG | 0.49899257 |
| 78 | LRRK2 | 0.49897665 |
| 79 | CDK14 | 0.49871544 |
| 80 | FES | 0.49151557 |
| 81 | ZAK | 0.49139925 |
| 82 | LYN | 0.48917944 |
| 83 | MAP3K1 | 0.48770453 |
| 84 | JAK1 | 0.47995089 |
| 85 | PRKG2 | 0.47649046 |
| 86 | CAMK1 | 0.47244443 |
| 87 | TRPM7 | 0.47023059 |
| 88 | FER | 0.47009577 |
| 89 | CDK5 | 0.46022820 |
| 90 | AKT1 | 0.44163705 |
| 91 | PRKCB | 0.43625707 |
| 92 | PRKD2 | 0.42704367 |
| 93 | ITK | 0.42482742 |
| 94 | PRKACA | 0.41589811 |
| 95 | BRSK1 | 0.38132937 |
| 96 | GRK6 | 0.37220389 |
| 97 | MELK | 0.36959126 |
| 98 | VRK1 | 0.35928005 |
| 99 | MAPK3 | 0.35270561 |
| 100 | CDK15 | 0.34762898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.72576033 |
| 2 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.55301836 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 2.96261901 |
| 4 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.80214579 |
| 5 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.76613708 |
| 6 | Salivary secretion_Homo sapiens_hsa04970 | 2.45880901 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.31302347 |
| 8 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.20832170 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.17662568 |
| 10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.08945187 |
| 11 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.00096556 |
| 12 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.96658989 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 1.96208788 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.90325199 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.85275132 |
| 16 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.77143993 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.70930884 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70639738 |
| 19 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.65772487 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61455218 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60333493 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59873672 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58775385 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.56459627 |
| 25 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.52589365 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.47796038 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.37492497 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36420599 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.25719362 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.24646521 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.18774780 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16099327 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.13031065 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10469296 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09088391 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04688299 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03095746 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01878581 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01153474 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98642831 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96822530 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96662085 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93059651 |
| 44 | Alcoholism_Homo sapiens_hsa05034 | 0.92252661 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.92185265 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89048487 |
| 47 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88813334 |
| 48 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.87214415 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84998689 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84798795 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84416918 |
| 52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.84229924 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81969980 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80798858 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80375078 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78118858 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 0.76830228 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76720099 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75818875 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71914880 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69583892 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69345578 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.68375516 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67325509 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65841870 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.64793060 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60359368 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.60159997 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59666280 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57347565 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53072023 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.52757452 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48733876 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48429976 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47639310 |
| 76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47214420 |
| 77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46386645 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45385633 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43858669 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.43742971 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43290675 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42104388 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41265723 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37230072 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37203238 |
| 86 | Melanoma_Homo sapiens_hsa05218 | 0.36510604 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35369256 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.33580249 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32236263 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31937927 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31924931 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31322923 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29169854 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28250102 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27928609 |
| 96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26754649 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26276604 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25359574 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24963923 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.24551412 |

